Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SERRINA M YOZSA

Podiatric Medicine & Surgery Service Providers Podiatrist

NPI
1720065113
CMS profile
214185
Location
SCOTTSDALE, AZ

General Payments · PY2018–2024

$19,694.95

  • Reported across 327 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$286.97

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $286.97 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $132.66 8
Paratek Pharmaceuticals, Inc. $107.31 6
DJO, LLC $24.73 1
ABBVIE INC. $22.27 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $13,930.51 83
PY2019 $1,047.95 65
PY2020 $1,832.50 51
PY2021 $886.20 40
PY2022 $866.96 45
PY2023 $843.86 27
PY2024 $286.97 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.27 07/17/2024 Food and Beverage Undisputed 01/23/2026 1106383330 CMS
Amgen Inc. $22.50 02/21/2024 Food and Beverage Undisputed 01/23/2026 1116220542 CMS
Amgen Inc. $19.71 03/29/2024 Food and Beverage Undisputed 01/23/2026 1116220545 CMS
Amgen Inc. $7.90 04/04/2024 Food and Beverage Undisputed 01/23/2026 1116220550 CMS
Amgen Inc. $6.68 04/23/2024 Food and Beverage Undisputed 01/23/2026 1116220556 CMS
Amgen Inc. $6.02 08/12/2024 Food and Beverage Undisputed 01/23/2026 1116220559 CMS
Amgen Inc. $19.75 08/27/2024 Food and Beverage Undisputed 01/23/2026 1116220564 CMS
Amgen Inc. $30.10 10/29/2024 Food and Beverage Undisputed 01/23/2026 1116220568 CMS
Amgen Inc. $20.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 1116220575 CMS
DJO, LLC $24.73 05/10/2024 Food and Beverage Undisputed 01/23/2026 1154740132 CMS
Paratek Pharmaceuticals, Inc. $16.19 02/06/2024 Food and Beverage Undisputed 01/23/2026 1113924406 CMS
Paratek Pharmaceuticals, Inc. $13.19 03/19/2024 Food and Beverage Undisputed 01/23/2026 1113924408 CMS
Paratek Pharmaceuticals, Inc. $17.45 06/27/2024 Food and Beverage Undisputed 01/23/2026 1113924410 CMS
Paratek Pharmaceuticals, Inc. $18.18 08/19/2024 Food and Beverage Undisputed 01/23/2026 1113924412 CMS
Paratek Pharmaceuticals, Inc. $24.71 10/21/2024 Food and Beverage Undisputed 01/23/2026 1113924414 CMS
Paratek Pharmaceuticals, Inc. $17.59 12/09/2024 Food and Beverage Undisputed 01/23/2026 1113924416 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.